TNNT2 and diabetes mellitus: GLS emerged as independent predictor of MACE after adjustment for measures of LV function (LVEF, MAPSE, LAS), myocardial injury (IS and MVO) angiographical (number of diseased vessels, infarct location) and clinical parameters (age, hypertension, diabetes, peak hs-cTnT) with superior prognostic validity compared to LVEF.